70 related articles for article (PubMed ID: 12730084)
1. Development of a genotype 325-specific proCPU/TAFI ELISA.
Gils A; Alessi MC; Brouwers E; Peeters M; Marx P; Leurs J; Bouma B; Hendriks D; Juhan-Vague I; Declerck PJ
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1122-7. PubMed ID: 12730084
[TBL] [Abstract][Full Text] [Related]
2. Development of ELISAs measuring the extent of TAFI activation.
Ceresa E; Brouwers E; Peeters M; Jern C; Declerck PJ; Gils A
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):423-8. PubMed ID: 16339503
[TBL] [Abstract][Full Text] [Related]
3. Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages.
Matus V; Willemse J; Quiroga T; Goycoolea M; Aranda E; Panes O; Pereira J; Hendriks D; Mezzano D
Clin Chim Acta; 2009 Mar; 401(1-2):158-61. PubMed ID: 19038242
[TBL] [Abstract][Full Text] [Related]
4. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
Heylen E; Miljic P; Willemse J; Djordjevic V; Radojkovic D; Colovic M; Elezovic I; Hendriks D
Thromb Res; 2009 Sep; 124(4):427-32. PubMed ID: 19195685
[TBL] [Abstract][Full Text] [Related]
5. Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma.
Strömqvist M; Schatteman K; Leurs J; Verkerk R; Andersson JO; Johansson T; Scharpé S; Hendriks D
Thromb Haemost; 2001 Jan; 85(1):12-7. PubMed ID: 11204563
[TBL] [Abstract][Full Text] [Related]
6. [Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients].
Kemona-Chetnik I; Kowal K; Kucharewicz I; Pampuch A; Bodzenta-Lukaszyk A
Przegl Lek; 2006; 63(12):1281-5. PubMed ID: 17642140
[TBL] [Abstract][Full Text] [Related]
7. TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.
Akatsu H; Yamagata H; Chen Y; Miki T; Kamino K; Takeda M; Campbell W; Kondo I; Kosaka K; Yamamoto T; Okada H
Br J Haematol; 2004 Nov; 127(4):440-7. PubMed ID: 15521922
[TBL] [Abstract][Full Text] [Related]
8. Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact.
Frère C; Morange PE; Saut N; Tregouet DA; Grosley M; Beltran J; Juhan-Vague I; Alessi MC
Thromb Haemost; 2005 Aug; 94(2):373-9. PubMed ID: 16113828
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor.
Develter J; Dewilde M; Gils A; Declerck PJ
Thromb Haemost; 2009 Jul; 102(1):69-75. PubMed ID: 19572070
[TBL] [Abstract][Full Text] [Related]
10. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
11. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
Boffa MB; Koschinsky ML
Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
[TBL] [Abstract][Full Text] [Related]
12. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
[TBL] [Abstract][Full Text] [Related]
13. Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysis.
Knecht W; Willemse J; Stenhamre H; Andersson M; Berntsson P; Furebring C; Harrysson A; Hager AC; Wissing BM; Hendriks D; Cronet P
FEBS J; 2006 Feb; 273(4):778-92. PubMed ID: 16441664
[TBL] [Abstract][Full Text] [Related]
14. Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyloid peptides.
El Mouedden M; Vandermeeren M; Meert T; Mercken M
J Neurosci Methods; 2005 Jun; 145(1-2):97-105. PubMed ID: 15922029
[TBL] [Abstract][Full Text] [Related]
15. Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma.
Heylen E; Van Goethem S; Willemse J; Olsson T; Augustyns K; Hendriks D
Anal Biochem; 2010 Jan; 396(1):152-4. PubMed ID: 19732738
[TBL] [Abstract][Full Text] [Related]
16. Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease.
Leurs J; Hendriks D
Thromb Haemost; 2005 Sep; 94(3):471-87. PubMed ID: 16268459
[TBL] [Abstract][Full Text] [Related]
17. TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays.
Schroeder V; Wilmer M; Buehler B; Kohler HP
Thromb Haemost; 2006 Aug; 96(2):236-7. PubMed ID: 16894472
[No Abstract] [Full Text] [Related]
18. Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.
Santamaría A; Borrell M; Oliver A; Ortín R; Forner R; Coll I; Mateo J; Souto JC; Fontcuberta J
Am J Hematol; 2004 Aug; 76(4):348-52. PubMed ID: 15282667
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of thrombin activatable fibrinolysis inhibitor in normal and preeclamptic pregnant women.
Alacacioğlu I; Ozcan MA; Alacacioğlu A; Polat M; Yüksel F; Demirkan F; Pişkin O; Ozgenç Y; Ozsan HG; Undar B
Thromb Res; 2004; 114(3):155-9. PubMed ID: 15342211
[TBL] [Abstract][Full Text] [Related]
20. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
